HIV/AIDS Program Announcements (PAs) and Requests for Applications (RFAs)

NIDA welcomes applications in response to PAs and RFAs as well as unsolicited applications. For information on electronic application submission requirements, go to http://era.nih.gov/ElectronicReceipt/.

Change in Standing Receipt Dates for AIDS and AIDS-related applications for NIH/AHRQ Beginning in May 2007 (NOT-OD-07-053) http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-07-053.html

NIDA Program Announcements

• Unique Interactions Between Tobacco Use and HIV/AIDS (R01) PA-08-253
• Unique Interactions Between Tobacco Use and HIV/AIDS (R03) PA-08-254
• Long Acting, Sustainable Therapies for Opiate Addiction (R01) PAS -08-061
• AIDS-Science Track Award for Research Transition (R03) PA-07-349
• Drug Abuse, Risky Decision Making and HIV/AIDS (R01) PAS-07-324
• Drug Abuse, Risky Decision Making and HIV/AIDS (R21) PAS-07-325
• Drug Abuse, Risky Decision Making and HIV/AIDS (R03) PAS-07-326
• Drug Abuse Aspects of HIV/AIDS (R01) PA-07-307
• Drug Abuse Aspects of HIV/AIDS (R03) PA-07-308
• Drug Abuse Aspects of HIV/AIDS (R21) PA-07-309
• International Research Collaboration on Drug Abuse and Addiction Research (R01)PA-09-020
• International Research Collaboration on Drug Abuse and Addiction Research (R21)PA-09-021
• International Research Collaboration on Drug Abuse and Addiction Research (R03)PA-09-022

Other Program Announcements in Which NIDA Participates

• Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R01) PA-08-188
• Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R21) PA-08-189
• Novel Lentiviral Models of HIV Neuropathogenesis (R01) PAS-08-178
• Novel Lentiviral Models of HIV Neuropathogenesis (R21) PAS-08-179
• Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21) PAR-08-153
• Prevention Research with HIV Positive Individuals (R01) PA-08-107
• Prevention Research with HIV Positive Individuals (R03) PA-08-108
• Prevention Research with HIV Positive Individuals (R21) PA-08-109
• PHASE II Comprehensive ICOHRTA AIDS/TB (U2R) PAR-08-155
• AIDS International Training and Research Program (D43) PAR-07-348
• HIV Treatment Adherence Research (R01) PA-07-338
• HIV Treatment Adherence Research (R03) PA-07-339
• HIV Treatment Adherence Research (R21) PA-07-340
• HIV/AIDS, Severe Mental Illness And Homelessness (R01) PA-07-090
• HIV Infection of the Central Nervous System (R01) PA-07-089
• Preclinical Therapeutics Development for NeuroAIDS (R03) PA-06-529
• Preclinical Therapeutics Development for NeuroAIDS (R21) PA-06-528

Notices

• Notice of Availability of Set-aside Funds for FY 2009 for PAS-08-019 (NOT-DA-08-019)
• Notice of Change of Resubmission Receipt Dates for AIDS-Science Track Award for Research Transition (R03) PA-07-349
• National Institute on Drug Abuse Policy on HIV Education, Counseling, Testing, and Treatment for Research Subjects (NOT-DA-07-013)
• Rationale for Modifications to the 2001 National Institute on Drug Abuse Policy on Counseling and Testing for HIV/AIDS and other Infectious Diseases

Joint NIDA/International AIDS Society Fellowship